Craig F Teller MD FAAD
Acne & Rosacea, Cosmetic Dermatology, Dermatologic Surgery, Pediatric Dermatology
Clinical Instructor, Dermatology, Baylor College of Medicine and McGovern UT school of Medicine
Join to View Full Profile
6565 West Loop SouthSte. 800Bellaire, TX 77401
Phone+1 713-661-4383
Dr. Teller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Craig Teller is a dermatologist in Bellaire, TX and is affiliated with multiple hospitals in the area, including Baylor St. Luke's Medical Center, Memorial Hermann Physician Network, and Memorial Hermann Southwest Hospital. He received his medical degree from McGovern Medical School at UTHealth and has been in practice 26 years. He specializes in acne & rosacea, cosmetic dermatology, and dermatologic surgery and is experienced in cosmetic dermatology, pediatric dermatology, complex medical dermatology, phlebology, and clincial trials. He has more than 10 publications and over 300 citings.
Education & Training
Baylor College of MedicineResidency, Dermatology, 1992 - 1995
University of Texas Health Science Center at HoustonInternship, Internal Medicine, 1991 - 1992
McGovern Medical School at UTHealthClass of 1991
Certifications & Licensure
TX State Medical License 1992 - 2027
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EMA, Modernizing Medicine, Inc., 2012, 2014
- Super Doctor SuperDoctors.com
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis Start of enrollment: 2019 Aug 12
- Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) Start of enrollment: 2020 Jun 15
- A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema) Start of enrollment: 2015 Mar 31
Publications & Presentations
PubMed
- How does canine atopic dermatitis provide a unique opportunity to study spectrum of care?Christina M Gentry, Laura Rey, Craig Teller, Lori Teller
Journal of the American Veterinary Medical Association. 2026-02-20 - 7 citationsBest Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician ConsiderationsCraig F Teller, Annie Chiu, Cameron Chesnut, Deborah Sherman, José Raúl Montes
Plastic and Reconstructive Surgery. Global Open. 2021-07-01 - 8 citationsATX-101 (Deoxycholic Acid Injection) Leads to Clinically Meaningful Improvement in Submental Fat: Final Data From CONTOUR.Kathleen L. Behr, Carmen M. Kavali, Girish Munavalli, Craig F Teller, Steve Yoelin
Dermatologic Surgery. 2020-05-01
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
